TY - JOUR
T1 - Restoring NK Cell Cytotoxicity Post-Cryopreservation via Synthetic Cells
AU - Zhou, Xiangda
AU - Zhang, Sijia
AU - Yang, Wenjuan
AU - Gonder, Susanne
AU - Sadjadi, Zeinab
AU - Piernitzki, Nils
AU - Moter, Alina
AU - Sharma, Shulagna
AU - Largeot, Anne
AU - Küchler, Nadja
AU - Kaschek, Lea
AU - Schäfer, Gertrud
AU - Schwarz, Eva C.
AU - Eichler, Hermann
AU - Ullrich, Evelyn
AU - Rieger, Heiko
AU - Staufer, Oskar
AU - Paggetti, Jérôme
AU - Moussay, Etienne
AU - Hoth, Markus
AU - Qu, Bin
N1 - Funding:
This project was funded by the Deutsche Forschungsgemeinschaft (DFG) for SFB 1027 (Project A2 to B.Q., Project A11 to M.H., Project A3 to H.R.), for the Emmy Noether program project 525255627 and project 545610076 to O.S., and for SFB/IRTG 1292 (Project-ID 318 346 496 to E.U., A.M.), by the “Large Equipment
Grants” program (GZ: INST 256/419-1 FUGG for the lightsheet micro-
scope, GZ: INST 256/423-1 FUGG for the flow cytometer, GZ: INST
256/429-1 FUGB for ImageXpress), by Leibniz-Institute for New Mate-
rials supporting B.Q. as INM Fellow, by Dr. Rolf M. Schwiete Stiftung
(project Nr. 2023–028 to M.H.), by Stiftung Deutsche Krebshilfe (Ger-
man Cancer Aid; “CAR FACTORY” #70 115 200 to E.U.), by the FNRS-
Télévie to S.G. (7.4502.19, 7.6604.21), by the Luxembourg National Re-
search Fund (FNR), Fondation Cancer and Plooschter Projet to A.L., E.M.
and J.P. (C20/BM/14 582 635, C20/BM/14 592 342, C23/BM/17 987 391,
and C24/BM/18 920 969)
Publisher Copyright:
© 2025 The Author(s). Advanced Science published by Wiley-VCH GmbH.
PY - 2025/11
Y1 - 2025/11
N2 - Natural killer (NK) cells are critical components of the first-line immune defense, responsible for eliminating tumorigenic cells. NK cell-based adoptive immunotherapy has gained increasing attention; however, cryopreservation, a standard technique for NK cell storage, significantly impairs NK cell cytotoxicity, particularly in physiological 3D environments. Here, we demonstrate that short-term co-culture with effector T cells markedly enhances NK cell motility and killing functionality. Notably, a brief 1-day co-culture is sufficient to restore cryopreservation-impaired NK cell functionality in 3D environments. This enhancement requires direct contact between T cells and NK cells, which facilitates localized high concentrations of IL-2 at the cell contact sites. To develop a controled, donor-independent solution, we demonstrate that synthetic T cells with surface-bound IL-2 exhibit superior efficiency in revitalizing cryopreserved NK cells. These findings uncover a previously unrecognized role for physical contact-mediated local IL-2 signaling and provide an efficient, cost-effective, and tunable strategy to rescue NK cell functionality post-cryopreservation, paving the way for more scalable, potent, and clinically viable NK cell-based immunotherapies.
AB - Natural killer (NK) cells are critical components of the first-line immune defense, responsible for eliminating tumorigenic cells. NK cell-based adoptive immunotherapy has gained increasing attention; however, cryopreservation, a standard technique for NK cell storage, significantly impairs NK cell cytotoxicity, particularly in physiological 3D environments. Here, we demonstrate that short-term co-culture with effector T cells markedly enhances NK cell motility and killing functionality. Notably, a brief 1-day co-culture is sufficient to restore cryopreservation-impaired NK cell functionality in 3D environments. This enhancement requires direct contact between T cells and NK cells, which facilitates localized high concentrations of IL-2 at the cell contact sites. To develop a controled, donor-independent solution, we demonstrate that synthetic T cells with surface-bound IL-2 exhibit superior efficiency in revitalizing cryopreserved NK cells. These findings uncover a previously unrecognized role for physical contact-mediated local IL-2 signaling and provide an efficient, cost-effective, and tunable strategy to rescue NK cell functionality post-cryopreservation, paving the way for more scalable, potent, and clinically viable NK cell-based immunotherapies.
KW - 3D
KW - cryopreservation
KW - cytotoxicity
KW - IL-2
KW - NK cells
KW - synthetic cells
KW - T cells
KW - Killer Cells, Natural/immunology
KW - T-Lymphocytes/immunology
KW - Humans
KW - Interleukin-2/metabolism
KW - Coculture Techniques/methods
KW - Cryopreservation/methods
KW - Immunotherapy, Adoptive/methods
KW - Cytotoxicity, Immunologic/immunology
UR - https://www.scopus.com/pages/publications/105016797640
UR - https://pubmed.ncbi.nlm.nih.gov/40966444/
U2 - 10.1002/advs.202505731
DO - 10.1002/advs.202505731
M3 - Article
C2 - 40966444
AN - SCOPUS:105016797640
SN - 2198-3844
VL - 12
JO - Advanced Science
JF - Advanced Science
IS - 42
M1 - e05731
ER -